TMO
Thermo Fisher Scientific Inc. · Healthcare · Medical - Diagnostics & Research
Input di momentum (manager comparabili):
ampiezza dei detentori +9.1% ·
flusso azionario +1.0% ·
nuove posizioni nette +8.3%
— formula
Accumulo diffuso — azioni in aumento tra un maggior numero di detentori
Tutte le cifre di proprietà: solo gestori 13F monitorati, posizioni in azioni ordinarie, periodo di riferimento Q4 2024
| Trimestre | Detentori | Δ | Quote | Valore dichiarato | Nuovo | Uscite |
|---|---|---|---|---|---|---|
| Q2 2026 | 191 | +3 | 260.61M | $131.45B | +5 | −1 |
| Q1 2026 | 190 | +2 | 255.88M | $126.62B | +7 | −6 |
| Q4 2025 | 187 | +3 | 274.75M | $159.19B | +4 | — |
| Q3 2025 | 29 | -1 | 154.46M | $74.90B | +1 | −3 |
| Q2 2025 | 28 | +3 | 123.95M | $50.25B | +3 | — |
| Q1 2025 | 22 | -2 | 60.64M | $30.17B | — | −2 |
| Q4 2024 | 24 | +2 | 61.50M | $31.99B | +2 | — |
| Q3 2024 | 21 | -2 | 44.46M | $27.48B | — | −2 |
| Q2 2024 | 23 | — | 44.78M | $24.75B | — | — |
| # | Gestore | Quote | Δ azioni | Valore | Il loro peso | Detenuto | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passivo) | 16.45M | — | $8.56B | 0.3% | n/c | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 10.92M | -0.5% | $5.68B | 0.7% | ▼ Trim | 3 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 10.92M | -0.5% | $5.68B | 0.7% | ▼ Trim | 3 | SEC ↗ |
| 4 | Capital World Investors ✦ | 9.43M | +1.1% | $4.91B | 0.7% | ▲ Add | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passivo) | 7.86M | +2.6% | $4.08B | 0.3% | ▲ Add | 3 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passivo) | 7.86M | +2.6% | $4.08B | 0.3% | ▲ Add | 3 | SEC ↗ |
| 7 | Norges Bank ✦ (passivo) | 6.05M | +8.3% | $3.15B | 0.4% | ▲ Add | 3 | SEC ↗ |
| 8 | Fisher Asset Management ✦ | 2.67M | +1.1% | $1.39B | 0.6% | ▲ Add | 3 | SEC ↗ |
| 9 | PRIMECAP Management ✦ | 2.51M | -2.7% | $1.30B | 1.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Wellington Management ✦ | 1.43M | -43.5% | $742.86M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 11 | Wellington Management ✦ | 1.43M | -43.5% | $742.86M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 12 | Wellington Management ✦ | 1.43M | -43.5% | $742.86M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 13 | Wellington Management ✦ | 1.43M | -43.5% | $742.86M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 14 | Wellington Management ✦ | 1.43M | -43.5% | $742.86M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 15 | Wellington Management ✦ | 1.43M | -43.5% | $742.86M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 16 | Wellington Management ✦ | 1.43M | -43.5% | $742.86M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 543.33K | +60.8% | $282.65M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 543.33K | +60.8% | $282.65M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 19 | Baillie Gifford ✦ | 538.86K | -10.7% | $280.33M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 20 | Baillie Gifford ✦ | 538.86K | -10.7% | $280.33M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 21 | Baillie Gifford ✦ | 538.86K | -10.7% | $280.33M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 22 | Baillie Gifford ✦ | 538.86K | -10.7% | $280.33M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 23 | Two Sigma Investments ✦ | 451.83K | +13.8% | $235.06M | 0.6% | ▲ Add | 3 | SEC ↗ |
| 24 | Adage Capital Partners ✦ | 390.31K | +9.1% | $203.05M | 0.4% | ▲ Add | 3 | SEC ↗ |
| 25 | Arrowstreet Capital ✦ | 369.29K | +79.0% | $192.11M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 26 | Third Point ✦ | 350.00K | Nuovo | $182.08M | 2.4% | New | 1 | SEC ↗ |
| 27 | Millennium Management ✦ | 342.38K | +179.6% | $178.12M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 28 | Citadel Advisors ✦ | 339.94K | +104.5% | $176.85M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 29 | Citadel Advisors ✦ | 339.94K | +104.5% | $176.85M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 30 | Marshall Wace ✦ | 330.32K | -47.4% | $171.84M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 31 | Marshall Wace ✦ | 330.32K | -47.4% | $171.84M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 32 | Marshall Wace ✦ | 330.32K | -47.4% | $171.84M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 221.20K | +4.6% | $115.08M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 221.20K | +4.6% | $115.08M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 221.20K | +4.6% | $115.08M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 36 | AQR Capital Management ✦ | 221.20K | +4.6% | $115.08M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 37 | AQR Capital Management ✦ | 221.20K | +4.6% | $115.08M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 38 | Renaissance Technologies ✦ | 181.34K | +270.5% | $94.34M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 39 | Markel Group ✦ | 41.10K | +16.1% | $21.38M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 40 | Point72 Asset Management ✦ | 39.10K | Nuovo | $20.34M | 0.1% | New | 1 | SEC ↗ |
| 41 | Gotham Asset Management ✦ | 29.35K | +25.4% | $15.27M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 42 | Dodge & Cox ✦ | 26.12K | -2.4% | $13.59M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 43 | GAMCO Investors ✦ | 4.13K | -3.5% | $2.15M | 0.0% | ▼ Trim | 3 | SEC ↗ |
"Il loro peso" = la quota della posizione sul valore azionario 13F dichiarato da quel gestore — la misura di convinzione. ✦ = gestore selezionato.
Nuovi acquirenti
| Third Point | $182.08M | 2.4% |
| Point72 Asset Management | $20.34M | 0.1% |
Uscito
| Nessuna uscita tracciata questo trimestre. |
Contesto di mercato completo: su TUTTI i filer 13F (dati strutturati SEC, Q1 2026): 1 detentori, 24.30K azioni, $11,944 dichiarato. Questo è un periodo diverso e più vecchio rispetto ai dati dell'universo monitorato riportati sopra e i due non vengono mai combinati.
Cosa detengono più spesso gli altri holder monitorati di questo titolo — conteggi di proprietà condivisa, non relazioni fondamentali.
Acquisti sul mercato aperto (P)
Nessun acquisto insider sul mercato aperto nella nostra finestra di copertura.
Vendite sul mercato aperto (S)
Officer, Director · 321 az. · $201,941
Officer, Director · 3.01K az. · $1.89M
Officer, Director · 1.79K az. · $1.12M
Officer, Director · 2.15K az. · $1.35M
Officer, Director · 2.73K az. · $1.71M
Officer, Director · 560 az. · $354,446
Officer, Director · 80 az. · $50,719
Officer, Director · 1.31K az. · $824,745
Officer, Director · 2.60K az. · $1.64M
Officer, Director · 1.25K az. · $787,312
Assegnazioni, esercizi e ritenute fiscali non vengono mai conteggiati come acquisti o vendite in questa sede. Metodologia